PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
 
Br J Cancer. 1991 December; 64(6): 985–989.
PMCID: PMC1977868

The EUROSCAN Study. EUROSCAN Steering Committee.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bichler E, Daxenbichler G. Retinoic acid-binding protein in human squamous cell carcinomas of the ORL region. Cancer. 1982 Feb 15;49(4):619–622. [PubMed]
  • Bendich A, Langseth L. Safety of vitamin A. Am J Clin Nutr. 1989 Feb;49(2):358–371. [PubMed]
  • Byers T. Diet and cancer. Any progress in the interim? Cancer. 1988 Oct 15;62(8 Suppl):1713–1724. [PubMed]
  • Colditz GA, Stampfer MJ, Willett WC. Diet and lung cancer. A review of the epidemiologic evidence in humans. Arch Intern Med. 1987 Jan;147(1):157–160. [PubMed]
  • De Flora S, Bennicelli C, Zanacchi P, Camoirano A, Morelli A, De Flora A. In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens. Carcinogenesis. 1984 Apr;5(4):505–510. [PubMed]
  • De Flora S. Detoxification of genotoxic compounds as a threshold mechanism limiting their carcinogenicity. Toxicol Pathol. 1984;12(4):337–343. [PubMed]
  • De Flora S, Bennicelli C, Camoirano A, Serra D, Romano M, Rossi GA, Morelli A, De Flora A. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds. Carcinogenesis. 1985 Dec;6(12):1735–1745. [PubMed]
  • De Flora S, Astengo M, Serra D, Bennicelli C. Inhibition of urethan-induced lung tumors in mice by dietary N-acetylcysteine. Cancer Lett. 1986 Sep;32(3):235–241. [PubMed]
  • de Vries N, Snow GB. Multiple primary tumours in laryngeal cancer. J Laryngol Otol. 1986 Aug;100(8):915–918. [PubMed]
  • de Vries N, Van der Waal I, Snow GB. Multiple primary tumours in oral cancer. Int J Oral Maxillofac Surg. 1986 Feb;15(1):85–87. [PubMed]
  • de Vries N, de Lange G, Drexhage HA, Snow GB. Immunoglobulin allotypes in head and neck cancer patients with multiple primary cancers. Acta Otolaryngol. 1987 Jul-Aug;104(1-2):187–191. [PubMed]
  • de Vries N, Drexhage HA, de Waal LP, de Lange G, Snow GB. Human leukocyte antigens and immunoglobulin allotypes in head and neck cancer patients with and without multiple primary tumors. Cancer. 1987 Sep 1;60(5):957–961. [PubMed]
  • de Vries N, Snow GB. Relationships of vitamins A and E and beta-carotene serum levels to head and neck cancer patients with and without second primary tumors. Eur Arch Otorhinolaryngol. 1990;247(6):368–370. [PubMed]
  • Fex G, Wahlberg P, Biörklund A, Wennerberg J, Willén R. Studies of cellular retinol-binding protein (CRBP) in squamous-cell carcinomas of the head and neck region. Int J Cancer. 1986 Feb 15;37(2):217–221. [PubMed]
  • Friedman GD, Blaner WS, Goodman DS, Vogelman JH, Brind JL, Hoover R, Fireman BH, Orentreich N. Serum retinol and retinol-binding protein levels do not predict subsequent lung cancer. Am J Epidemiol. 1986 May;123(5):781–789. [PubMed]
  • Goepfert H. Are we making any progress? Arch Otolaryngol. 1984 Sep;110(9):562–563. [PubMed]
  • Gluckman JL, Crissman JD, Donegan JO. Multicentric squamous-cell carcinoma of the upper aerodigestive tract. Head Neck Surg. 1980 Nov-Dec;3(2):90–96. [PubMed]
  • Gluckman JL, Crissman JD. Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract. Laryngoscope. 1983 Jan;93(1):71–74. [PubMed]
  • Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990 Sep 20;323(12):795–801. [PubMed]
  • Hordijk GJ, de Jong JM. Synchronous and metachronous tumours in patients with head and neck cancer. J Laryngol Otol. 1983 Jul;97(7):619–621. [PubMed]
  • Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK. Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst. 1990 Apr 4;82(7):555–560. [PubMed]
  • Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):691–694. [PubMed]
  • Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med. 1986 Nov 13;315(20):1250–1254. [PubMed]
  • Middleton B, Byers T, Marshall J, Graham S. Dietary vitamin A and cancer--a multisite case-control study. Nutr Cancer. 1986;8(2):107–116. [PubMed]
  • Pastorino U, Chiesa G, Infante M, Soresi E, Clerici M, Valente M, Belloni PA, Ravasi G. Safety of high-dose vitamin A. Randomized trial on lung cancer chemoprevention. Oncology. 1991;48(2):131–137. [PubMed]
  • Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature. 1981 Mar 19;290(5803):201–208. [PubMed]
  • Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J. 1979 Nov 3;2(6198):1097–1100. [PMC free article] [PubMed]
  • Schantz SP, Hsu TC. Mutagen-induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients. Head Neck. 1989 Jul-Aug;11(4):337–342. [PubMed]
  • Schantz SP, Spitz MR, Hsu TC. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst. 1990 Nov 21;82(22):1773–1775. [PubMed]
  • SILVERMAN S, Jr, RENSTRUP G, PINDBORG JJ. STUDIES IN ORAL LEUKOPLAKIAS. III. EFFECTS OF VITAMIN A COMPARING CLINICAL, HISTOPHATHOLOGIC, CYTOLOGIC, AND HEMATOLOGIC RESPONSES. Acta Odontol Scand. 1963 Jun;21:271–292. [PubMed]
  • Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, Newell GR, Schantz SP. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 1989 Aug 15;49(16):4626–4628. [PubMed]
  • Tepperman BS, Fitzpatrick PJ. Second respiratory and upper digestive tract cancers after oral cancer. Lancet. 1981 Sep 12;2(8246):547–549. [PubMed]
  • Tuyns AJ. Epidemiology of alcohol and cancer. Cancer Res. 1979 Jul;39(7 Pt 2):2840–2843. [PubMed]
  • Vrabec DP. Multiple primary malignancies of the upper aerodigestive system. Ann Otol Rhinol Laryngol. 1979 Nov-Dec;88(Pt 1):846–854. [PubMed]
  • Wilpart M, Speder A, Roberfroid M. Anti-initiation activity of N-acetylcysteine in experimental colonic carcinogenesis. Cancer Lett. 1986 Jun;31(3):319–324. [PubMed]
  • WYNDER EL, BROSS IJ, DAY E. A study of environmental factors in cancer of the larynx. Cancer. 1956 Jan-Feb;9(1):86–110. [PubMed]
  • WYNDER EL, BROSS IJ, FELDMAN RM. A study of the etiological factors in cancer of the mouth. Cancer. 1957 Nov-Dec;10(6):1300–1323. [PubMed]
  • Ziegler RG, Mason TJ, Stemhagen A, Hoover R, Schoenberg JB, Gridley G, Virgo PW, Altman R, Fraumeni JF., Jr Dietary carotene and vitamin A and risk of lung cancer among white men in New Jersey. J Natl Cancer Inst. 1984 Dec;73(6):1429–1435. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK